CRLF2 and precursor B-cell acute lymphoblastic leukemia: Here, we developed novel GEMMs of human B-ALL through transgenic overexpression of Crlf2 and concomitant expression of mutant Jak2 to determine the role of mutant JAK2 in leukemia initiation and maintenance of disease.